Suppr超能文献

PCR 技术在巴西萨尔瓦多市用于鉴别诊断和检测溶组织内阿米巴/迪斯帕内阿米巴的流行率的验证和应用。

Validation and utilization of PCR for differential diagnosis and prevalence determination of Entamoeba histolytica/Entamoeba dispar in Salvador City, Brazil.

机构信息

Health and Investigative Medicine Biotechnology, FIOCRUZ, Bahia, Brazil.

出版信息

Braz J Infect Dis. 2011 Mar-Apr;15(2):119-25.

Abstract

UNLABELLED

Amoebiasis is an infection caused by Entamoeba histolytica and is a potential health risk in countries in which health barriers are inappropriate. Since the discovery of Entamoeba dispar, the prevalence of amoebiasis has been modified.

OBJECTIVE

This study has standardized the PCR technique applied for the diagnosis of different species of the E. histolytica/E. dispar complex and has evaluated the prevalence of infection among patients attending private and public clinical laboratories in Salvador City, Bahia State, Brazil.

RESULTS

Analysis of 52,704 stool samples by microscopic examination demonstrated that 1,788 (3.4%) were positive for the E. histolytica/E. dispar complex and infection occurred more often in samples originated from public clinical laboratories (5.0%) than those that came from private laboratories (3.2%). PCR performed in approximately 15% (262) E. histolytica/E. dispar complex positive samples, randomly chosen, amplified 227 samples (86.6%), all of them positive for E. dispar. The non-amplified 35 samples (13.4%) were also negative for E. histolytica-specific galactose adhesin. Moreover, to exclude a probable infection caused by E. hartmanni, morphometric analysis demonstrated that non-amplified samples had cyst sizes comparable to E. histolytica/E. dispar (>10 µm).

CONCLUSION

The absence of amplification of these samples indicates the presence of PCR inhibitors in the stool samples or the presence of DNA from Entamoeba species other than E. dispar, E. histolytica or E. hartmanni.

摘要

未加标签

阿米巴病是由溶组织内阿米巴引起的感染,在卫生条件不适当的国家是一种潜在的健康风险。自从发现迪斯帕内阿米巴以来,阿米巴病的流行情况发生了变化。

目的

本研究标准化了用于诊断溶组织内阿米巴/迪斯帕内阿米巴复合体不同种的 PCR 技术,并评估了巴西萨尔瓦多市私人和公共临床实验室就诊患者的感染率。

结果

通过显微镜检查分析了 52704 份粪便样本,结果显示 1788 份(3.4%)为溶组织内阿米巴/迪斯帕内阿米巴复合体阳性,公共临床实验室(5.0%)的样本感染率高于私人实验室(3.2%)。对随机选择的约 15%(262 份)溶组织内阿米巴/迪斯帕内阿米巴复合体阳性样本进行 PCR 检测,扩增了 227 份(86.6%)样本,均为迪斯帕内阿米巴阳性。未扩增的 35 份(13.4%)样本也为阴性,未检测到针对溶组织内阿米巴特异性半乳糖结合素。此外,为排除可能由 E. hartmanni 引起的感染,形态计量分析表明,未扩增样本的囊大小与溶组织内阿米巴/迪斯帕内阿米巴相似(>10 µm)。

结论

这些样本未扩增表明粪便样本中存在 PCR 抑制剂,或存在除迪斯帕内阿米巴、溶组织内阿米巴或 E. hartmanni 以外的内阿米巴属种的 DNA。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验